Navigation Links
ER study finds 1 in 10 older teens misuse Rx painkillers & sedatives
Date:10/29/2013

ANN ARBOR, Mich. With prescription drug abuse at epidemic levels nationwide, and overdoses killing more people than auto accidents in many states, a new University of Michigan study provides striking new data about the misuse of potent prescription painkillers and sedatives by teens and young adults.

In all, 10.4 percent of the teens and young adults treated in the emergency room for any reason admitted to misusing a prescription painkiller or sedative at least once in the last year, the study finds. That included taking the drugs to get high, taking more of the drug than was prescribed to them, or taking drugs prescribed to someone else.

What's more, most of this use was apparently illicit: The vast majority of those who admitted this use had no prescriptions for these drugs on their medical records.

The study also raises the possibility that emergency room visits, for any reason, could become important occasions for detecting and addressing prescription drug problems among young people.

The results are published in a new online-first paper in the journal Pediatrics, by a team from the U-M Medical School and U-M Injury Center. They draw their data from a large, confidential, tablet-based survey of 2,135 people between the ages of 14 and 20 years, conducted in 2010 and 2011 during visits to the U-M Health System's adult and pediatric emergency departments.

It's the first time this issue has been studied in an emergency department setting even though ER doctors often prescribe opioid painkillers and sedatives for emergency use. They also care for many patients who have accidentally or intentionally overdosed on these drugs. In fact, the Centers for Disease Control and Prevention has estimated that 100 deaths per day, and around 700,000 emergency department (ED) visits per year, result from prescription drug overdoses.

School-based studies have found rates of misuse among young people to be around 8 percent. But such studies miss those who have dropped out of school or did not continue their education past high school.

Lauren Whiteside, M.D., who led the study during her U-M Injury Center postdoctoral research fellowship, says the findings suggest that emergency department could be an effective setting for screening teens and young adults for prescription drug misuse, and for intervening early before problems arise.

She also noted that it's important for emergency physicians to be aware of the risk that patients could be seeking drugs for misuse or diversion to others when they come to the ER.

The study reveals several risk factors that were associated with non-medical use of prescription painkillers and sedatives.

For instance, those who misused painkillers were more likely to receive an intravenous opioid painkiller during their ER visit. And across the board, those who misused prescription drugs were significantly more likely to have also abused alcohol and non-prescription drugs such as cough medicine, or to have used marijuana, in the past year. They were also more likely to have ridden with a drunken driver.

"These patients are often using the emergency department for their medical care, not primary care settings," says Whiteside. "So, in order to curb this problem and address overdose and addiction, the ED is a good place to start."

She notes that because the study was performed in one emergency setting, further study is needed to validate the findings. And more research to develop and test screening tools and interventional tactics will be needed.

Whiteside, who is now at the University of Washington, worked with U-M Injury Center director and U-M associate professor of emergency medicine Rebecca Cunningham, M.D., on the study. The two continue to work together on this topic, and the U-M Injury Center continues to seek solutions to the growing epidemic.

The ER as a setting for screening and intervention has also been raised in research on other issues including alcohol abuse, non-prescription "hard" drug abuse and violence.

But, says Whiteside, "One of the main differences between non-medical prescription opioid and sedative misuse and other drug use is that the emergency physician is providing the substance. It's a really difficult thing to tackle and requires a multipronged effort."

Cunningham notes that, "It will likely take a concerted effort at the state level, with improved information systems aiding prescribing physicians to identify youth at risk, a change in prescribing practices that take into account the epidemic and the public health crisis, and improved early screening and intervention to change the current rising trend of overdose deaths related to prescription medications."

The study asked teens and young adults about their use of the prescription opioids fentanyl, oxycodone, hydrocodone, methadone, buprenorphine, and suboxone, and the sedatives Valium, Serepax, Ativan, Xanax, Librium, Rohypnol, and GHB, among others.


'/>"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Male birth defect is weakly linked to pesticide exposure, Stanford-led study finds
2. RI Hospital study measures impact of education, information on hand hygiene compliance
3. Miriam Hospital researcher awarded $2.9 million NIH grant to study impact of maternal smoking
4. ER study finds 1 in 10 older teens misuse Rx painkillers & sedatives
5. New study: Enterocystoplasty in children with genitourinary abnormalities is safe and effective
6. New Study Confirms Patent Assertion Is a Growing and Costly Burden on Innovation Ecosystem
7. New study on neurodevelopmental effects of prenatal exposure to paracetamol
8. Study to assess impact of health reform in India
9. Pregnant women with hepatitis C may pass heartier viral strain to newborns, study suggests
10. First ever study of moral distress among nurses in burn unit
11. Young fibromyalgia patients report worse symptoms than older patients, Mayo Clinic study shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 2016 , ... This campaign aims to provide a path to improved education ... control and change. , As nearly 795,000 Americans suffering from a new or recurrent ... Plus, with an estimated 129,000 of these people dying from stroke, it’s become our ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... stories, courtesy of leaders in the nursing and health care industry. It also ... advocates and associations—namely Jones & Bartlett Learning. , Jones & Bartlett Learning is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports ... Yellen and company to wait until March 2017 for an interest rate increase, according ... Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot charts are ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... Florida (PRWEB) , ... May 26, 2016 , ... ... House® Project offering a new model of care for living and healing, celebrated ... core values: Meaningful Life in a Real Home provided by Empowered Staff. , “This ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. ... Regenerative Medicine, Neurology and Orphan Diseases, today announced that President & ... upcoming investor conferences: SeeThru Equity MicroCap Conference   ... New York City , NY When: Tuesday, May ... Conference   Where: Grand Hyatt Hotel, 109 East 42 ...
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: